News
-
A team of specialist researchers in Melbourne believe they have found a major response that helps keep the Legionella infection at bay.
-
Professor O’Hair, from the University’s School of Chemistry and Bio21 Institute's study has been published in Nature Communications today.
-
Professor Ary Hoffmann from the School of BioSciences and Bio21 Institute at the University of Melbourne has been elected into the American Academy of Arts and Sciences as a Foreign Honorary Member — Evolutionary and Population Biology, and Ecology.
-
Associate Professor Uta Wille, Professor Leann Tilley, Dr Diana Stojanovski and Dr Kathryn Tiedje
By Florienne Loder
-
By Dr Ben Phillips, Dr Andrew Weeks and Professor Ary Hoffmann, School of Biosciences, University of Melbourne.
-
CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia
-
Clarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).
-
Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.
-
Katherine Davies, Kimberley Callaghan, Wassif Kabir, Marycarol Holdaway and Gemma van Duijneveldt.
-
Dr Andrew Cuthbertson, CSL Chief Scientific Officer, The Governor of Victoria, The Honourable Linda Dessau, The Chancellor, Elizabeth Alexander AM, Dr Andrew Nash, Senior Vice President, Research, CSL Ltd.